146 related articles for article (PubMed ID: 35953276)
21. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients.
Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Scholz M; Kraft G; Wannenmacher M; Debus J
Strahlenther Onkol; 2003 Sep; 179(9):598-605. PubMed ID: 14628125
[TBL] [Abstract][Full Text] [Related]
22. MR Imaging Grading System for Skull Base Chordoma.
Tian K; Wang L; Ma J; Wang K; Li D; Du J; Jia G; Wu Z; Zhang J
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1206-1211. PubMed ID: 28428207
[TBL] [Abstract][Full Text] [Related]
23. Role of Apparent Diffusion Coefficient Map-Based First- and High-Order Radiomic Features for the Discrimination of Sacral Chordomas and Chondrosarcomas With Overlapping Conventional Imaging Features.
Amini B; Chenglei L; Duran-Sierra E; Wang WL; Canjirathinkal MA; Moradi H; Green WN; Madewell JE; Costelloe CM; Murphy WA; Valenzuela RF
JCO Precis Oncol; 2023 Sep; 7():e2300243. PubMed ID: 38127828
[TBL] [Abstract][Full Text] [Related]
24. MRI Signal Intensity and Electron Ultrastructure Classification Predict the Long-Term Outcome of Skull Base Chordomas.
Bai J; Shi J; Zhang S; Zhang C; Zhai Y; Wang S; Li M; Li C; Zhao P; Geng S; Gui S; Jing L; Zhang Y
AJNR Am J Neuroradiol; 2020 May; 41(5):852-858. PubMed ID: 32381547
[TBL] [Abstract][Full Text] [Related]
25. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.
Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H
Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275
[TBL] [Abstract][Full Text] [Related]
26. Challenges in linear accelerator radiotherapy for chordomas and chondrosarcomas of the skull base: focus on complications.
Hauptman JS; Barkhoudarian G; Safaee M; Gorgulho A; Tenn S; Agazaryan N; Selch M; De Salles AA
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):542-51. PubMed ID: 22137019
[TBL] [Abstract][Full Text] [Related]
27. Proton radiation therapy for chordomas and chondrosarcomas of the skull base.
Hug EB; Slater JD
Neurosurg Clin N Am; 2000 Oct; 11(4):627-38. PubMed ID: 11082173
[TBL] [Abstract][Full Text] [Related]
28. Kinase Activity in Recurring Primary Skull Base Chordomas and Chondrosarcomas: Identification of Novel Pathways of Oncogenesis and Potential Drug Targets.
Tatman PD; Osbun J; Yakkioui Y; Kaur S; Parada C; Busald T; Born D; Ahmad O; Zhang J; Ferreira M
World Neurosurg; 2017 Nov; 107():75-81. PubMed ID: 28647652
[TBL] [Abstract][Full Text] [Related]
29. [Pathology of myxoid bone tumors of the skull base].
Gavril C; Bouvier C; Liprandi A; Dufour H; Peragut JC; Zanaret M; Figarella-Branger D
Ann Pathol; 2002 Sep; 22(4):259-66. PubMed ID: 12410148
[TBL] [Abstract][Full Text] [Related]
30. Proton radiation therapy for chordomas and chondrosarcomas of the skull base.
Hug EB; Loredo LN; Slater JD; DeVries A; Grove RI; Schaefer RA; Rosenberg AE; Slater JM
J Neurosurg; 1999 Sep; 91(3):432-9. PubMed ID: 10470818
[TBL] [Abstract][Full Text] [Related]
31. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases.
Wojno KJ; Hruban RH; Garin-Chesa P; Huvos AG
Am J Surg Pathol; 1992 Dec; 16(12):1144-52. PubMed ID: 1463093
[TBL] [Abstract][Full Text] [Related]
32. Normalized Parameters of Dynamic Contrast-Enhanced Perfusion MRI and DWI-ADC for Differentiation between Posttreatment Changes and Recurrence in Head and Neck Cancer.
Baba A; Kurokawa R; Rawie E; Kurokawa M; Ota Y; Srinivasan A
AJNR Am J Neuroradiol; 2022 Aug; 43(8):1184-1189. PubMed ID: 35835592
[TBL] [Abstract][Full Text] [Related]
33. T1-Weighted Dynamic Contrast-Enhanced MR Perfusion Imaging Characterizes Tumor Response to Radiation Therapy in Chordoma.
Santos P; Peck KK; Arevalo-Perez J; Karimi S; Lis E; Yamada Y; Holodny AI; Lyo J
AJNR Am J Neuroradiol; 2017 Nov; 38(11):2210-2216. PubMed ID: 28912284
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of skull base chordomas from chondrosarcomas by diffusion-weighted MRI.
Freeze BS; Glastonbury CM
AJNR Am J Neuroradiol; 2013 Oct; 34(10):E113. PubMed ID: 23945231
[No Abstract] [Full Text] [Related]
35. [A clinicopathological and immunohistochemical study of 34 cases of chordoma].
Hu Y; Gao Y; Zhang X
Zhonghua Bing Li Xue Za Zhi; 1996 Jun; 25(3):142-4. PubMed ID: 9275666
[TBL] [Abstract][Full Text] [Related]
36. Radiotherapy for chordomas and low-grade chondrosarcomas of the skull base with carbon ions.
Schulz-Ertner D; Haberer T; Jäkel O; Thilmann C; Krämer M; Enghardt W; Kraft G; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):36-42. PubMed ID: 12007939
[TBL] [Abstract][Full Text] [Related]
37. Proton therapy for skull base tumors: A review of clinical outcomes for chordomas and chondrosarcomas.
Mercado CE; Holtzman AL; Rotondo R; Rutenberg MS; Mendenhall WM
Head Neck; 2019 Feb; 41(2):536-541. PubMed ID: 30537295
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a new concept for the management of skull base chordomas and chondrosarcomas.
Feigl GC; Bundschuh O; Gharabaghi A; Safavi-Abassi S; El Shawarby A; Samii M; Horstmann GA
J Neurosurg; 2005 Jan; 102 Suppl():165-70. PubMed ID: 15662803
[TBL] [Abstract][Full Text] [Related]
39. The Added Value of Diffusion Magnetic Resonance Imaging in the Diagnosis and Posttreatment Evaluation of Skull Base Chordomas.
Guler E; Ozgen B; Mut M; Soylemezoglu F; Oguz KK
J Neurol Surg B Skull Base; 2017 Jun; 78(3):256-265. PubMed ID: 28593113
[No Abstract] [Full Text] [Related]
40. Treatment with high marginal dose is mandatory to achieve long-term control of skull base chordomas and chondrosarcomas by means of stereotactic radiosurgery.
Koga T; Shin M; Saito N
J Neurooncol; 2010 Jun; 98(2):233-8. PubMed ID: 20419388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
